Serial 79248825

Live / Registered — Registered — Section 71 accepted (as of 13 Aug 2026)

What this means for you

Registered since 12 Nov 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Nov 2029: the §71 ten-year affidavit of use).

Record

Serial number
79248825
Registration number
5905800
Mark type
Design / logo
Filed
10 Aug 2018
Published for opposition
27 Aug 2019
Registered
12 Nov 2019
Next maintenance filing
§71 ten-year affidavit of use, due by 12 Nov 2029 (grace period to 12 May 2030)
Attorney of record
Kathryn E. Smith

Goods and services

  • Class 005 — Pharmaceuticals: Medicines for human purposes, namely, medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; [ bacterial poisons; ] pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; [ chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; ] prescription drugs for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; [ medicines for dental purposes; ] chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease [ ; antibiotics; pharmaceutical preparations in the form of injectionable pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, infectious diseases, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals; active pharmaceutical ingredients in the nature of drug delivery agents in the form of tablets, lozenges, chews, gels, fast dispersing dosage forms, films, ovules, sprays, buccal/mucoadhesive patches for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories; medicinal oils; transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; candy, medicated; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances in the nature of foods and beverages adapted for medical use; mineral food supplements; nutritional supplements ]

Owner

Prosecution history

  • 13 Aug 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
  • 13 Aug 2026 — REGISTERED-SEC.71 ACCEPTED
  • 10 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 28 Apr 2026 — TEAS SECTION 71 RECEIVED
  • 23 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
  • 07 Nov 2025 — CHANGE OF OWNER RECEIVED FROM IB
  • 21 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 21 Aug 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
  • 21 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 21 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 21 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 21 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 12 Nov 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 01 Apr 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 01 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED

View this trademark record on Rightsy